• RSL3: Glutathione Peroxidase 4 Inhibitor

  2026-08-26

  RSL3 is a direct GPX4-targeting tool for modeling ferroptosis, with practical value in redox assays, glioma studies, and RAS-driven cancer research. This workflow-focused guide connects cell-death phenotyping with GPX4 expression analysis, rescue experiments, and troubleshooting for more interpretable results.

• GANT61 and the Hh–PIK3IP1–Akt Axis in ALK+ ALCL

  2026-08-25

  A 2026 study identifies a potential signaling connection between Gli1 inhibition, PIK3IP1 upregulation, and reduced Akt phosphorylation in ALK-positive anaplastic large cell lymphoma. Its integrated cell-based and transcriptomic approach supports GANT61 as a mechanistic probe for suppressing lymphoma growth, while the findings remain primarily preclinical and require causal and in vivo validation.

• DAPT in Human Sensory Neuron Assays

  2026-08-24

  DAPT (GSI-IX) enables mechanistic interrogation of γ-secretase and Notch signaling in advanced neuronal models. This article connects its biochemical profile with a human hiPSC-derived sensory neuron system for studying assay design, HSV-1 latency, and pathway-specific interpretation.

• HyperFusion High-Fidelity DNA Polymerase

  2026-08-24

  HyperFusion high-fidelity DNA polymerase supports accurate genotyping, cloning, and sequencing workflows for complex templates. This article connects its proofreading chemistry to the causal neurobiology of pheromone-driven neurodegeneration in C. elegans while defining practical assay limits.

• VX-661 and the Proteostasis Logic of CFTR Rescue

  2026-08-23

  VX-661 is more than a trafficking aid: it is a strategic probe of how proteostasis, variant biology, and assay design determine F508del CFTR rescue. This thought-leadership analysis connects corrector pharmacology with calnexin-dependent quality control and translational cystic fibrosis research.

• Lipid Peroxidation (MDA) Assay Kit Guide

  2026-08-22

  Learn how to use the Lipid Peroxidation (MDA) Assay Kit for reproducible malondialdehyde measurement in kidney, cell, plasma, serum, and urine models. This practical guide connects dual-mode detection with ferroptosis research, matrix-aware workflows, and troubleshooting strategies.

• ATRX Loss Sensitizes Glioma to PDGFR Inhibitors

  2026-08-21

  Pladevall-Morera et al. used an FDA-approved drug screen and follow-up cellular experiments to show that ATRX-deficient high-grade glioma cells are more vulnerable to multi-targeted RTK and PDGFR inhibition. The study also reports enhanced toxicity when RTK inhibition is combined with temozolomide, supporting ATRX-stratified interpretation of targeted-therapy studies while leaving in vivo efficacy and mechanism-specific questions open.

• FTSJ3 Loss, R-Loops, and Lung Cancer Chemosensitivity

  2026-08-20

  The 2025 Cancer Letters study identifies FTSJ3 as a regulator of R-loop homeostasis and genomic stability in lung cancer cells. Its depletion increases R-loop-associated DNA damage and enhances cisplatin sensitivity in cellular and in vivo models, supporting further evaluation of FTSJ3 as a chemotherapy-response biomarker and therapeutic vulnerability.

• WST-8 Glucose Uptake Assay: From Signal to Mechanism

  2026-08-20

  A glucose uptake assay can reveal how autophagy disruption and insulin resistance reshape cellular metabolism. This guide connects WST-8 chemistry with the Galectin-1–FIP200 findings in hepatic steatosis and offers a rigorous framework for interpreting uptake data.

• Epalrestat and KEAP1/Nrf2 Neuroprotection in PD

  2026-08-19

  Jia et al. identify Epalrestat, an established aldose reductase inhibitor, as a candidate neuroprotective agent in cellular and mouse Parkinson’s disease models. The study’s central advance is evidence that Epalrestat directly engages KEAP1, promotes KEAP1 degradation, and activates Nrf2-associated antioxidant defenses while reducing oxidative stress, mitochondrial dysfunction, and dopaminergic neuron injury.

• Trolox and Lipid Peroxidation: Smarter Assay Design

  2026-08-19

  Trolox is more than a routine antioxidant control: it can help test whether oxidative lipid damage contributes to cellular injury. This mechanism-aware guide explains how to interpret Trolox responses alongside lipid peroxidation, viability, and pathway-specific evidence.

• SARS-CoV-2 Variant Shifts in ACE2 Usage

  2026-08-18

  Shukla et al. developed a barcoded pseudotyped-virus assay that simultaneously measures how SARS-CoV-2 spike variants use diverse ACE2 sequences. The study shows that variant-associated changes are modest for human ACE2 but can substantially reshape compatibility with animal ACE2 orthologs, providing a scalable framework for studying receptor adaptation and cross-species entry.

• Ampicillin Sodium as a Reproducibility Control

  2026-08-18

  Ampicillin sodium is more than a selection antibiotic: it can serve as a traceable experimental variable linking bacterial genetics, protein purification, and antibacterial activity assays. This article uses recombinant annexin V purification to show how selection history and formulation control improve reproducibility.

• Cell Death in Liver Disease: Mechanisms & Relevance

  2026-08-17

  Luedde, Kaplowitz, and Schwabe’s review reframes hepatocyte death as both a clinical biomarker and a causal driver of inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Its central contribution is the context-specific comparison of apoptosis, necrosis, and necroptosis, together with the damage-associated responses that determine whether liver injury resolves or progresses.

• LRRC8A–Caveolin-1 Signaling in PDAC

  2026-08-17

  The reference study identifies a cholesterol-dependent LRRC8A–Caveolin-1 axis that connects cell-volume regulation with KRAS/EGFR signaling, ribosome biogenesis, and pancreatic ductal adenocarcinoma growth. Its combination of genetic, pharmacological, organoid, xenograft, and biochemical approaches provides a framework for studying how membrane organization supports biosynthetic expansion in PDAC.

8527 records 2/569 page Previous Next 12345 下5页 Last page